Indian J Pharm Close
 

Figure 2: Immunohistochemistry images. [a] Tumor cells showing cytoplasmic positivity for glypican - 3, [b] nuclear positivity for SALL4, [c] Negativity for OCT3/4, and [d] negativity for CD117. [e] Photograph of patient after six cycles of chemotherapy

Figure 2: Immunohistochemistry images. [a] Tumor cells showing cytoplasmic positivity for glypican - 3, [b] nuclear positivity for SALL4, [c] Negativity for OCT3/4, and [d] negativity for CD117. [e] Photograph of patient after six cycles of chemotherapy